API sees profit slump

Half-year results show a 14.4% drop in reported net profit, which API says is primarily due to challenging retail conditions For the half year ending 28 February 2018, Australian Pharmaceutical Industries (API) has revealed an 8.1% decrease in underlying net profit after tax (NPAT), from $29.1 million at this time last year to $26.8 million.